Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...

NATICK, Mass.--(BUSINESS WIRE)--AffyImmune Therapeutics, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, today announced early results from a ...

HOUSTON ― Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in ...

The impact of sociodemographic factors on thyroid cancer trends in the United States: A retrospective study using SEER database. Ropeginterferon alfa-2b versus anagrelide for the treatment of ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge. A recent review published in Genes & Diseases offers a comprehensive ...

A pre-surgical combination therapy including pembrolizumab plus dabrafenib and trametinib (DTP) significantly improved survival in patients with rare BRAF V600E-mutated anaplastic thyroid cancer ...

MONDAY, Nov. 17, 2025 (HealthDay News) — Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of ...

Bengaluru: Thyroid cancer can easily be missed at the beginning stages. There are no dramatic signals - only small, subtle ...

Your thyroid is a small, butterfly-shaped gland in the front of your neck. Its main job is to produce thyroid hormones, which help regulate your body's metabolism and control your heart rate, body ...